TRAVERE THERAPEUTICS, INC. Restructuring Reserve, Accrual Adjustment
TRAVERE THERAPEUTICS, INC. (TVTX) reported Restructuring Reserve, Accrual Adjustment of $200.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-24.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveAccrualAdjustment1 · last filed 2020-02-24
- TRAVERE THERAPEUTICS, INC. restructuring reserve, accrual adjustment for the quarter ending 2017-12-31 was $3.65M.
- TRAVERE THERAPEUTICS, INC. restructuring reserve, accrual adjustment for the quarter ending 2017-09-30 was -$55.00K.
- TRAVERE THERAPEUTICS, INC. restructuring reserve, accrual adjustment for fiscal 2018 was $200.00K, a 94.44% decline from fiscal 2017.
- TRAVERE THERAPEUTICS, INC. restructuring reserve, accrual adjustment for fiscal 2017 was $3.60M.
| Period end | Restructuring Reserve, Accrual Adjustment 3 month | Restructuring Reserve, Accrual Adjustment 3 month as first filed | Restructuring Reserve, Accrual Adjustment 6 month | Restructuring Reserve, Accrual Adjustment 9 month | Restructuring Reserve, Accrual Adjustment 12 month | Restructuring Reserve, Accrual Adjustment 12 month as first filed |
|---|---|---|---|---|---|---|
| 2018-12-31 | $200.00K 10-K · filed 2020-02-24 | -$242.00K 10-K · filed 2019-02-26 | ||||
| 2017-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $3.60M derived: sum of 2 quarters · filed 2020-02-24 | $3.60M 10-K · filed 2020-02-24 | -$55.00K 10-K · filed 2019-02-26 | ||
| 2017-09-30 | -$55.00K 10-K · filed 2018-07-06 | $0.00 10-Q · filed 2017-11-07 | -$55.00K 10-Q · filed 2017-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |